Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNinety One Regulatory News (N91)

Share Price Information for Ninety One (N91)

Share Price is delayed by 15 minutes
Get Live Data
214.20    0.20 (0.09%)
Bid:
214.00
Ask:
214.20
Spread: 0.20 (0.093%)
Market Cap: £2.07b
N91 Live PriceLast checked at - London Stock Exchange

Intraday Ninety One Share Chart

Directorate Changes

4 Jun 2025 07:01

RNS Number : 2942L
Ninety One PLC
04 June 2025
 

Ninety One Limited Incorporated in the Republic of South Africa

Registration number 2019/526481/06

Date of registration: 18 October 2019JSE share code: NY1

ISIN: ZAE000282356

 

Ninety One plc Incorporated in England and Wales

Registration number 12245293

Date of registration: 4 October 2019LSE share code: N91

JSE share code: N91

ISIN: GB00BJHPLV88

LEI: 549300G0TJCT3K15ZG14

 

 

 

As part of the dual-listed companies' structure, Ninety One plc and Ninety One Limited notify both the LSE and the JSE of matters which are required to be disclosed under the Disclosure Guidance and Transparency Rules and Listing Rules of the FCA and/or the Listings Requirements of the JSE.

 

 

DIRECTOR RETIREMENT

 

Ninety One plc and Ninety One Limited (together "Ninety One" and "the Board") announce that Colin Keogh, independent non-executive director of Ninety One, has informed the Board that he will not be seeking re-election at the forthcoming Annual General Meetings ("AGM") on Wednesday, 23 July 2025, and will retire from Ninety One at the conclusion of that meeting.

 

The Board wishes to thank Colin for his contributions to Ninety One during a period of great change for the business and wishes him well with his future endeavours.

APPOINTMENT OF NON-EXECUTIVE DIRECTOR

 

At the same time the Board is pleased to confirm the appointment of Mr Charles Harman as an independent non-executive director of the Board of Ninety One, with effect from 24 July 2025. Charles will be appointed to the Ninety One Audit and Risk Committee and the Ninety One Human Capital and Remuneration Committee at the same time.

 

Charles brings over thirty years of investment banking experience, leadership in capital markets, corporate finance, and risk oversight. His prior roles include Managing Director at Credit Suisse, Head of UK Investment Banking at J.P. Morgan Cazenove, and Chief Executive Officer of BXR Partners. He is currently the external Deputy Chair of Council of the University of Oxford. Charles will stand for election by Ninety One's shareholders at the Company's 2026 AGM.

 

The Board congratulates Charles on his appointment as a non-executive director of the Board and looks forward to working with him in the coming years.

 

CHANGES TO DIRECTOR APPOINTMENTS

 

With effect from 24 July 2025, Busisiwe Mabuza, who has served on the Board since November 2019, will be appointed as Senior Independent Director and Chair of the Ninety One Human Capital and Remuneration Committee. Khumo Shuenyane, who has served on the Board since August 2021, will replace Busisiwe Mabuza as Chair of the Ninety One Sustainability, Social and Ethics Committee.

 

This announcement has been made pursuant to the UK Listing Rule 6.4.6R and JSE Limited Listing Requirements paragraph 3.59

There are no further details required to be disclosed by Rule 6.4.8R of the UK Listing Rules.

 

4 June 2025

 

JSE Sponsor:

J.P. Morgan Equities South Africa Proprietary Limited

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOASSWFADEISEDM
Date   Source Headline
11th Apr 20257:00 amRNSTransaction in Own Shares
10th Apr 20257:00 amRNSTransaction in Own Shares
9th Apr 20253:00 pmRNSResult of General Meetings
9th Apr 20257:00 amRNSTransaction in Own Shares
8th Apr 20252:00 pmRNSDealing in Securities by Employee Benefit Trusts
8th Apr 20257:00 amRNSTransaction in Own Shares
7th Apr 20252:00 pmRNSDealing in Securities by Employee Benefit Trusts
7th Apr 20257:00 amRNSTransaction in Own Shares
4th Apr 20257:00 amRNSTransaction in Own Shares
3rd Apr 20257:00 amRNSTransaction in Own Shares
2nd Apr 20257:00 amRNSTransaction in Own Shares
1st Apr 20252:00 pmRNSDealing in Securities by Employee Benefit Trusts
1st Apr 20252:00 pmRNSDealing in Securities by Employee Benefit Trusts
1st Apr 20257:00 amRNSTransaction in Own Shares
31st Mar 20254:40 pmRNSTotal Voting Rights
31st Mar 20253:30 pmRNSShare repurchase programme
31st Mar 20251:30 pmRNSDealing in Securities by Employee Benefit Trusts
31st Mar 20251:30 pmRNSDealing in Securities by Employee Benefit Trusts
31st Mar 20257:00 amRNSTransaction in Own Shares
28th Mar 20252:30 pmRNSDealing In Securities By Employee Benefit Trusts
28th Mar 20257:00 amRNSTransaction in Own Shares
27th Mar 20253:00 pmRNSDirector/PDMR Shareholding
27th Mar 20257:00 amRNSTransaction in Own Shares
26th Mar 20257:00 amRNSTransaction in Own Shares
25th Mar 20252:30 pmRNSDealing In Securities By Employee Benefit Trusts
25th Mar 20257:00 amRNSTransaction in Own Shares
24th Mar 20252:30 pmRNSDealing In Securities By Employee Benefit Trusts
24th Mar 20259:30 amRNSDealing In Securities By Employee Benefit Trusts
24th Mar 20257:30 amRNSTransaction in Own Shares
21st Mar 20257:00 amRNSTransaction in Own Shares
20th Mar 20257:00 amRNSTransaction in Own Shares
19th Mar 20252:30 pmRNSDealing In Securities By Employee Benefit Trusts
18th Mar 20252:30 pmRNSDealing In Securities By Employee Benefit Trusts
17th Mar 20252:30 pmRNSDealing In Securities By Employee Benefit Trusts
17th Mar 20252:30 pmRNSDealing In Securities By Employee Benefit Trusts
14th Mar 20252:30 pmRNSDealing In Securities By Employee Benefit Trusts
14th Mar 20257:00 amRNSTransaction in Own Shares
13th Mar 20252:30 pmRNSDirector/PDMR Shareholding
13th Mar 20257:00 amRNSTransaction in Own Shares
12th Mar 20253:30 pmRNSDealing In Securities By Employee Benefit Trusts
12th Mar 20257:00 amRNSTransaction in Own Shares
11th Mar 20252:30 pmRNSDealing in Securities By Employee Benefit Trusts
11th Mar 20257:00 amRNSTransaction in Own Shares
10th Mar 20252:30 pmRNSDealing in Securities By Employee Benefit Trusts
7th Mar 20257:00 amRNSTransaction in Own Shares
6th Mar 20253:12 pmRNSPublication of a Circular & Notice of GM
6th Mar 20257:05 amRNSExecution of Key Operative Agreements
6th Mar 20257:00 amRNSShare repurchase programme
18th Feb 20252:30 pmRNSHolding(s) in Company
3rd Feb 20252:30 pmRNSDealing in Securities by Employee Benefit Trusts

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.